Get the Stockscreener App
4.74
1.46%
-0.04
Sophia Genetics Sa stock is traded at $4.74, with a volume of 81,643.
It is down -1.46% in the last 24 hours and down -8.54% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$4.78
Open:
$4.79
24h Volume:
81,643
Relative Volume:
0.48
Market Cap:
$321.60M
Revenue:
$64.49M
Net Income/Loss:
$-71.40M
P/E Ratio:
-4.3486
EPS:
-1.09
Net Cash Flow:
$-52.00M
1W Performance:
+2.39%
1M Performance:
-8.54%
6M Performance:
+50.00%
1Y Performance:
+23.95%
1-Day Range:
$4.6132
$4.80
1-Week Range:
$4.6132
$5.06
52-Week Range:
$2.58
$5.70
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH vs VEEV, TEM, BTSG, HQY, DOCS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
4.74 | 324.31M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
170.66 | 29.10B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
49.80 | 9.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
38.45 | 7.22B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
74.63 | 6.57B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
24.59 | 4.80B | 550.17M | 201.35M | 232.07M | 1.00 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
Day Trade: Can SOPHiA GENETICS SA sustain its profitabilityJuly 2025 Action & Long-Term Investment Growth Plans - baoquankhu1.vn
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems - Finviz
SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer - Quantisnow
Aug Wrap: Can SOPHiA GENETICS SA sustain its profitability2025 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn
Painful week for individual investors invested in SOPHiA GENETICS SA (NASDAQ:SOPH) after 11% drop, institutions also suffered losses - simplywall.st
VIX Spike: Is SOPHiA GENETICS SA benefiting from interest rate changesJuly 2025 Sector Moves & Precise Trade Entry Recommendations - baoquankhu1.vn
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 68.3% - MarketBeat
SOPHiA GENETICS Expands Perceptive Credit Facility With New $25 Million Term Loan Capacity and Additional Warrants - The Globe and Mail
Sophia Genetics amends credit agreement to add $25 million in loan commitments By Investing.com - Investing.com Nigeria
Sophia Genetics amends credit agreement to add $25 million in loan commitments - Investing.com Nigeria
1,409,160 Shares in SOPHiA GENETICS SA $SOPH Bought by Alta Wealth Advisors LLC - Defense World
Market Trends: Is SOPHiA GENETICS SA a potential multi baggerWeekly Investment Summary & Capital Protection Trading Alerts - baoquankhu1.vn
SOPHiA GENETICS (NASDAQ:SOPH) Trading Down 0.7%Here's What Happened - MarketBeat
SOPH: Guggenheim Raises Price Target While Maintaining Buy Ratin - GuruFocus
Growth Recap: Is SOPHiA GENETICS SA a momentum stockJuly 2025 Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Pharma News: Is SOPHiA GENETICS SA benefiting from interest rate changesSwing Trade & Growth Focused Stock Pick Reports - baoquankhu1.vn
Market Catalysts: Is SOPHiA GENETICS SA exposed to political riskQuarterly Performance Summary & AI Powered Market Entry Strategies - baoquankhu1.vn
Setup Watch: How does BTC Digital Ltd perform in inflationary periodsPortfolio Growth Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Stop Loss: Can SOPHiA GENETICS SA continue delivering strong returnsWeekly Trade Recap & Verified Swing Trading Watchlist - baoquankhu1.vn
Big Money Moves: Is SOPHiA GENETICS SA exposed to political riskWeekly Trade Review & Proven Capital Preservation Tips - baoquankhu1.vn
Why analysts recommend SOPHiA GENETICS SA (90B) stockMarket Performance Summary & Free Fast Entry Momentum Trade Alerts - bollywoodhelpline.com
Sentiment Review: Why is SOPHiA GENETICS SA stock going downJuly 2025 Drop Watch & Stock Timing and Entry Methods - baoquankhu1.vn
Aug Levels: Is SOPHiA GENETICS SA stock a hidden gemJuly 2025 Review & Risk Managed Trade Strategies - baoquankhu1.vn
Inside the platform analyzing 1.8M genomes to speed cancer insights - Stock Titan
Executive hires to help startups scale - Startupticker.ch
Aug Final Week: Is SOPHiA GENETICS SA a potential multi baggerQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
SOPHiA GENETICS Announces CEO Transition and Strong Preliminary 2025 Results - TipRanks
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan - marketscreener.com
SOPHiA GENETICS reports 20% revenue growth, plans CEO transition By Investing.com - Investing.com UK
SOPHiA GENETICS Reports Strong Q3 Growth and Raises Guidance - MSN
Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleJuly 2025 Action & Growth Oriented Trade Recommendations - Улправда
Will SOPHiA GENETICS SA stock maintain dividend yieldMarket Sentiment Review & Daily Risk Controlled Trade Plans - ulpravda.ru
Why SOPHiA GENETICS SA stock remains on buy listsQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - Улправда
Published on: 2026-01-09 00:00:10 - ulpravda.ru
Will SOPHiA GENETICS SA (90B) stock outperform global peersJuly 2025 Market Mood & High Accuracy Trade Alerts - ulpravda.ru
Is SOPHiA GENETICS SA stock ready for breakoutQuarterly Market Summary & Free Safe Entry Trade Signal Reports - Улправда
Income Plays: Can SOPHiA GENETICS SA (90B) stock ride next bull market cycleWeekly Investment Recap & High Return Stock Watch Alerts - Улправда
MD Anderson, SOPHiA GENETICS Join for AI Oncology Boost - Mirage News
Aug Sectors: Is SOPHiA GENETICS SA stock ready for breakoutWeekly Trade Analysis & Long Hold Capital Preservation Tips - Bộ Nội Vụ
How SOPHiA GENETICS SA stock benefits from global expansionStock Rotation Strategies & Access Free Risk Analysis Before You Invest - ulpravda.ru
Tech Rally: Will SOPHiA GENETICS SA 90B stock outperform global peers2025 Market Outlook & Free Fast Entry Momentum Trade Alerts - Bộ Nội Vụ
Sophia Genetics stock rises on MD Anderson Cancer Center partnership - Investing.com
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology - Finviz
SOPHiA GENETICS and MD Anderson partner on AI-driven cancer care - Investing.com UK
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and Clover Health Investments (NASDAQ:CLOV) - Defense World
Will SOPHiA GENETICS SA stock benefit from upcoming earnings reports2026 world cup usa national team semifinals star players low block defense group prediction expert opinion - ulpravda.ru
Can Nirlon Limited (500307) Maintain Its ValuationMarket Capitalization Trends & Our Picks = Your Future Gains - bollywoodhelpline.com
RSI Reset May Fuel Rebound in Sanstar LimitedMerger & Acquisition Updates & Outperform With Our Smart Trading Calculator - bollywoodhelpline.com
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.13%
1.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):